Rituxan and Orencia, an RA drug from Bristol-Myers Squibb, give doctors an expanded arsenal.

FORBES: Genentech's Next Act

They include Abilify for schizophrenia and bipolar disorder, Reyataz for HIV, Orencia for rheumatoid arthritis and Sprycel for chronic myelogenous leukemia.

FORBES: Why Bristol And Sanofi Shouldn't Merge

The drug abatacept (Orencia) had been rejected in 2008.

BBC: More arthritis drugs to be made available on the NHS